Variant report

Variant	esv3315142
Chromosome Location	chr17:15182127-15186725
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:90)
CpG islands
(count:62)
Chromatin interactive
region (count:4)
LncRNA
region (count:2)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:90 , 50 per page) page: 1 2

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF3	chr17:15182197-15182865	A549	lung:	n/a	n/a
2	BACH1	chr17:15182481-15182691	H1-hESC	embryonic stem cell:	n/a	n/a
3	BCL3	chr17:15182154-15182949	A549	lung:	n/a	n/a
4	BCL3	chr17:15182050-15183046	A549	lung:	n/a	n/a
5	BHLHE40	chr17:15182288-15182846	A549	lung:	n/a	n/a
6	BRCA1	chr17:15182443-15182785	Hela-S3	cervix:	n/a	n/a
7	CEBPB	chr17:15185127-15185551	MCF-7	breast:	n/a	n/a
8	CEBPB	chr17:15185177-15185512	HepG2	liver:	n/a	n/a
9	CEBPB	chr17:15185144-15185529	HepG2	liver:	n/a	n/a
10	CEBPB	chr17:15182191-15182802	A549	lung:	n/a	chr17:15182212-15182223
11	CEBPB	chr17:15182010-15182749	IMR90	lung:	n/a	chr17:15182212-15182223
12	CEBPB	chr17:15185168-15185511	Hela-S3	cervix:	n/a	n/a
13	CEBPB	chr17:15185220-15185382	HepG2	liver:	n/a	n/a
14	CEBPB	chr17:15182334-15182592	MCF-7	breast:	n/a	n/a
15	CEBPB	chr17:15185150-15185532	IMR90	lung:	n/a	n/a
16	CEBPB	chr17:15185126-15185445	ECC-1	luminal epithelium:	n/a	n/a
17	CEBPB	chr17:15181932-15182733	A549	lung:	n/a	chr17:15182212-15182223
18	CEBPB	chr17:15182246-15182696	Hela-S3	cervix:	n/a	n/a
19	CEBPB	chr17:15185220-15185528	H1-hESC	embryonic stem cell:	n/a	n/a
20	CEBPB	chr17:15185153-15185422	HepG2	liver:	n/a	n/a
21	CEBPB	chr17:15185094-15185596	MCF-7	breast:	n/a	n/a
22	CEBPB	chr17:15185182-15185520	ECC-1	luminal epithelium:	n/a	n/a
23	CEBPB	chr17:15185212-15185442	A549	lung:	n/a	n/a
24	CEBPB	chr17:15185162-15185560	A549	lung:	n/a	n/a
25	CEBPB	chr17:15181830-15182994	A549	lung:	n/a	chr17:15182212-15182223
26	CEBPB	chr17:15185173-15185515	K562	blood:	n/a	n/a
27	E2F4	chr17:15182292-15182749	MCF10A-Er-Src	breast:	n/a	n/a
28	E2F4	chr17:15185360-15185377	MCF10A-Er-Src	breast:	n/a	n/a
29	EP300	chr17:15182099-15182984	A549	lung:	n/a	n/a
30	EP300	chr17:15181766-15182997	A549	lung:	n/a	n/a
31	FOS	chr17:15182228-15182839	MCF10A-Er-Src	breast:	n/a	n/a
32	FOS	chr17:15183549-15183577	MCF10A-Er-Src	breast:	n/a	n/a
33	FOS	chr17:15182338-15182784	MCF10A-Er-Src	breast:	n/a	n/a
34	FOS	chr17:15182235-15182841	MCF10A-Er-Src	breast:	n/a	n/a
35	FOS	chr17:15182040-15182858	MCF10A-Er-Src	breast:	n/a	n/a
36	FOSL1	chr17:15182379-15182884	HCT-116	colon:	n/a	n/a
37	FOSL2	chr17:15181765-15183135	A549	lung:	n/a	n/a
38	FOSL2	chr17:15182353-15182858	MCF-7	breast:	n/a	n/a
39	FOSL2	chr17:15182230-15182873	A549	lung:	n/a	n/a
40	FOXA2	chr17:15182188-15182938	A549	lung:	n/a	n/a
41	FOXA2	chr17:15182132-15182894	A549	lung:	n/a	n/a
42	GABPA	chr17:15182199-15182879	A549	lung:	n/a	n/a
43	GATA3	chr17:15182200-15182886	A549	lung:	n/a	n/a
44	GATA3	chr17:15182015-15183186	A549	lung:	n/a	n/a
45	HNF4A	chr17:15185237-15185393	HepG2	liver:	n/a	n/a
46	JUN	chr17:15182579-15182793	K562	blood:	n/a	n/a
47	JUND	chr17:15182202-15182839	Hela-S3	cervix:	n/a	chr17:15182645-15182656 chr17:15182614-15182625
48	JUND	chr17:15182177-15182886	A549	lung:	n/a	chr17:15182645-15182656 chr17:15182614-15182625
49	JUND	chr17:15182504-15182731	HepG2	liver:	n/a	chr17:15182645-15182656 chr17:15182614-15182625
50	JUND	chr17:15182540-15182777	K562	blood:	n/a	chr17:15182645-15182656 chr17:15182614-15182625

(count:62 , 50 per page) page: 1 2

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr17:15183229-15183279	SK-N-SH	brain:	n/a
2	chr17:15183229-15183279	SK-N-SH	brain:	n/a
3	chr17:15183229-15183279	GM12878	blood:	n/a
4	chr17:15183229-15183279	HL-60	blood:	n/a
5	chr17:15183229-15183279	NHDF-neo	bronchial:	n/a
6	chr17:15183229-15183279	NH-A	brain:	n/a
7	chr17:15183229-15183279	HEK293	kidney:	embryo
8	chr17:15183229-15183279	MCF10A-Er-Src	breast:	n/a
9	chr17:15183229-15183279	RPTEC	kidney:	n/a
10	chr17:15183229-15183279	HPAEpiC	pulmonary alveolar:	n/a
11	chr17:15183229-15183279	AG04450	lung:	fetal
12	chr17:15183229-15183279	CMK	blood:	n/a
13	chr17:15183229-15183279	T-47D	breast:	n/a
14	chr17:15183229-15183279	HRE	kidney:	n/a
15	chr17:15183229-15183279	AG10803	skin:	n/a
16	chr17:15183229-15183279	HCPEpiC	choroid plexus:	n/a
17	chr17:15183229-15183279	HepG2	liver:	n/a
18	chr17:15183229-15183279	A549	lung:	n/a
19	chr17:15183229-15183279	HCT-116	colon:	n/a
20	chr17:15183229-15183279	HUVEC	blood vessel:	n/a
21	chr17:15183229-15183279	AoSMC	blood vessel:	n/a
22	chr17:15183229-15183279	SAEC	small airway:	n/a
23	chr17:15183229-15183279	H1-hESC	embryonic stem cell:	embryo
24	chr17:15183229-15183279	NB4	blood:	n/a
25	chr17:15183229-15183279	PFSK-1	brain:	n/a
26	chr17:15183229-15183279	GM19239	blood:	n/a
27	chr17:15183229-15183279	MCF-7	breast:	n/a
28	chr17:15183229-15183279	PANC-1	pancreas:	n/a
29	chr17:15183229-15183279	SK-N-MC	brain:	n/a
30	chr17:15183229-15183279	Hela-S3	cervix:	n/a
31	chr17:15183229-15183279	U87	brain:	n/a
32	chr17:15183229-15183279	K562	blood:	n/a
33	chr17:15183229-15183279	HAEpiC	amniotic membrane:	n/a
34	chr17:15183229-15183279	PrEC	prostate:	n/a
35	chr17:15183229-15183279	GM06990	blood:	n/a
36	chr17:15183229-15183279	Hepatocyte	liver:	n/a
37	chr17:15183229-15183279	ECC-1	luminal epithelium:	n/a
38	chr17:15183229-15183279	HCM	heart:	n/a
39	chr17:15183229-15183279	HRPEpiC	eye:	n/a
40	chr17:15183229-15183279	Jurkat	blood:	n/a
41	chr17:15183229-15183279	GM12892	blood:	n/a
42	chr17:15183229-15183279	NT2-D1	testis:	n/a
43	chr17:15183229-15183279	BJ	skin:	n/a
44	chr17:15183229-15183279	ovcar-3	ovarian:	n/a
45	chr17:15183229-15183279	AG04449	skin:	fetal
46	chr17:15183229-15183279	IMR90	lung:	fetal
47	chr17:15183229-15183279	AG09319	gingival:	n/a
48	chr17:15183229-15183279	HMEC	breast:	n/a
49	chr17:15183229-15183279	HEEpiC	esophagus:	n/a
50	chr17:15183229-15183279	LNCaP	prostate:	n/a

(count:4 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr17:15182846..15185726-chr17:15187592..15189351,3	MCF-7	breast:
2	chr17:15176128..15178880-chr17:15180153..15182408,3	MCF-7	breast:
3	chr17:15166393..15169688-chr17:15179101..15182406,4	MCF-7	breast:
4	chr17:15182819..15184688-chr17:15250956..15253066,2	K562	blood:

(count:2 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-PMP22-2	chr17:15182656-15182794	XLOC_012397
2	lnc-PMP22-2	chr17:15182656-15182832	XLOC_012397

No data

Variant related genes	Relation type
ENSG00000237377	TF binding region
ENSG00000237377	CpG island
ENSG00000109099	chromatin interactions

Extended variants
information (count: 164 )
Associated
traits (count: 133 )

Variant overlapped rSNPs/rCNVs (count:164 , 50 per page) page: 1 2 3 4

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs74325426	chr17:15182147-15182148	Flanking Active TSS Enhancers Bivalent Enhancer Active TSS Bivalent/Poised TSS Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
2	rs185556310	chr17:15182179-15182180	Flanking Active TSS Enhancers Bivalent Enhancer Active TSS Bivalent/Poised TSS Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
3	rs231011	chr17:15182209-15182210	Flanking Active TSS Enhancers Active TSS Weak transcription	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
4	rs537475402	chr17:15182238-15182239	Flanking Active TSS Enhancers Active TSS Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
5	rs149740848	chr17:15182247-15182248	Flanking Active TSS Enhancers Active TSS Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
6	rs551432031	chr17:15182266-15182267	Flanking Active TSS Enhancers Active TSS Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
7	rs548659732	chr17:15182291-15182292	Flanking Active TSS Enhancers Active TSS Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
8	rs1870430	chr17:15182359-15182360	Flanking Active TSS Enhancers Active TSS Weak transcription	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
9	rs534384404	chr17:15182366-15182367	Flanking Active TSS Enhancers Active TSS Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
10	rs554368910	chr17:15182376-15182377	Flanking Active TSS Enhancers Active TSS Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
11	rs1870429	chr17:15182380-15182381	Flanking Active TSS Enhancers Active TSS Weak transcription	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
12	rs542550600	chr17:15182397-15182398	Flanking Active TSS Enhancers Active TSS Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
13	rs146734196	chr17:15182415-15182416	Enhancers Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs74531720	chr17:15182466-15182467	Enhancers Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs116353976	chr17:15182469-15182470	Enhancers Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs565377164	chr17:15182473-15182474	Enhancers Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs572407396	chr17:15182482-15182483	Enhancers Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs530550964	chr17:15182525-15182526	Enhancers Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs541128746	chr17:15182529-15182530	Enhancers Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs559886456	chr17:15182560-15182561	Enhancers Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs115723371	chr17:15182579-15182580	Enhancers Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs550334938	chr17:15182583-15182584	Enhancers Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs548847670	chr17:15182585-15182586	Enhancers Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs562666568	chr17:15182623-15182624	Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs531332610	chr17:15182660-15182661	Flanking Active TSS Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
26	rs551132803	chr17:15182662-15182663	Flanking Active TSS Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
27	rs571233877	chr17:15182667-15182668	Flanking Active TSS Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
28	rs533827503	chr17:15182669-15182670	Flanking Active TSS Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
29	rs547540834	chr17:15182688-15182689	Flanking Active TSS Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
30	rs189237832	chr17:15182707-15182708	Flanking Active TSS Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
31	rs140325896	chr17:15182718-15182719	Flanking Active TSS Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
32	rs556974624	chr17:15182737-15182738	Flanking Active TSS Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
33	rs75648274	chr17:15182767-15182768	Flanking Active TSS Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
34	rs200696286	chr17:15182829-15182830	Flanking Active TSS Enhancers Weak transcription	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
35	rs576712494	chr17:15182929-15182930	Flanking Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs192880544	chr17:15182956-15182957	Flanking Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs144310788	chr17:15182964-15182965	Flanking Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs572128498	chr17:15183003-15183004	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs374909001	chr17:15183015-15183016	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs561077350	chr17:15183058-15183059	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs184442707	chr17:15183092-15183093	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs201427336	chr17:15183097-15183098	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs542501292	chr17:15183100-15183101	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs146564986	chr17:15183107-15183108	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs9894454	chr17:15183182-15183183	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
46	rs377699695	chr17:15183183-15183184	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs188442664	chr17:15183192-15183193	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
48	rs558702117	chr17:15183203-15183204	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs564701743	chr17:15183229-15183230	Enhancers Weak transcription Flanking Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
50	rs76476804	chr17:15183230-15183231	Enhancers Weak transcription Flanking Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:133)

Disease	PMID	Source
Burkitt''s lymphoma	18698080	CNVD
Breast cancer	17603634	CNVD
Melanoma	18172304	CNVD
Glioblastoma multiforme	19435819	CNVD
Non-small cell lung cancer	19010865	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Colorectal cancer	16774939	CNVD
Hepatocellular carcinoma	18803288	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Burkitt''s lymphoma	19759907	CNVD
Wilms tumour	21544195	CNVD
Esophageal adenocarcinoma	18519675	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Medulloblastoma	21979893	CNVD
Breast cancer	16608533	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Chordoma	21602918	CNVD
Miller-Dieker syndrome	22283845	CNVD
Non-syndromic sensorineural hearing loss	17457615	CNVD
Cancer	22429812	CNVD
Chronic lymphocytic leukemia	21795749	CNVD
Ewing''s sarcoma	21437220	CNVD
Follicular lymphoma	19010834	CNVD
Colorectal cancer	20709793	CNVD
Acute myeloid leukemia	16864856	CNVD
Endometrial cancer	22040021	CNVD
Paraganglioma	21461997	CNVD
Pheochromocytoma	21461997	CNVD
Breast cancer	22028636	CNVD
Breast cancer	20837533	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Hepatocellular carcinoma	22174799	CNVD
Medulloblastoma	21292688	CNVD
colon cancer	17210682	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Basal cell lymphoma	17053054	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Cancer	16751803	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Colorectal cancer	19359472	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Chronic lymphocytic leukemia	17971485	CNVD
Basal cell lymphoma	17170743	CNVD
Breast cancer	16461572	CNVD
Colorectal cancer	16272173	CNVD
Follicular lymphoma	17170743	CNVD
Human rectal carcinomas	16397240	CNVD
Breast cancer	17133270	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Ovarian cancer	22174824	CNVD
Moyamoya disease	22323933	CNVD
small cell lung cancer	20016488	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Urothelial carcinoma	21177765	CNVD
Acute myeloid leukemia	21251322	CNVD
Myelodysplastic syndrome	21251322	CNVD
Cancer	20164919	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Acute myeloid leukemia	20724749	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
Acute myeloid leukemia	17237825	CNVD
Colorectal cancer	21645411	CNVD
HIV/AIDS	22844521	CNVD
Psoriasis	22844521	CNVD
Rheumatoid arthritis	22844521	CNVD
Sclerosis systemic	22844521	CNVD
Systemic lupus erythematosus	22844521	CNVD
HIV/AIDS	17953491	CNVD
HIV/AIDS	20877625	CNVD
Immune disease	21076436	CNVD
Rheumatoid arthritis	17953491	CNVD
Type 1 diabetes	17953491	CNVD
HIV/AIDS	15637236	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Ovarian cancer	21781307	CNVD
Autism	22495311	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Neurofibromatosis	18196300	CNVD
Adenoid cystic carcinoma	18332873	CNVD
Multiple myeloma	16616336	CNVD
Multiple myeloma	17550852	CNVD
Breast cancer	21509527	CNVD
Sezary syndrome	18413736	CNVD
Pancreatic cancer	21811587	CNVD
Autism	17322880	CNVD
Hereditary neuropathy with liability to pressure palsy	19521722	CNVD
Schizophrenia	19571808	CNVD
Schizophrenia	19955444	CNVD
Charcot-marie-tooth disease	18787571	CNVD
Breast cancer	20409316	CNVD
Autism	18414403	CNVD
Breast cancer	17001317	CNVD
Rhabdomyosarcoma	16790082	CNVD
Myelofibrosis	22110671	CNVD
Peripheral neuropathy	21193943	CNVD
Schizophrenia	20587603	CNVD
Schizophrenia	22958593	CNVD
Cutaneous T-cell lymphoma	21881587	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Ovarian cancer	20844748	CNVD
Barrett''s adenocarcinoma	18663352	CNVD
Charcot-marie-tooth disease	16463004	CNVD
Osteosarcoma	22292074	CNVD
Charcot	16760730	CNVD
Mental retardation	17901693	CNVD
ovarian endometriomas	16273235	CNVD
Breast cancer	21858162	CNVD
Ovarian cancer	21720365	CNVD
Bipolar disorder	19114987	CNVD
Schizophrenia	20967226	CNVD
Autism	18522746	CNVD
Epilepsy	21635232	CNVD
Autism	22543975	CNVD
Obesity	20622171	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	17142309	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:81 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr17:15173200-15192600	Weak transcription	Left Ventricle	heart
2	chr17:15180000-15182400	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
3	chr17:15180800-15183600	Enhancers	Hela-S3	cervix
4	chr17:15181200-15182200	Enhancers	iPS-20b Cell Line	embryonic stem cell
5	chr17:15181200-15182400	Enhancers	HUES64 Cell Line	embryonic stem cell
6	chr17:15181400-15182200	Enhancers	iPS-18 Cell Line	embryonic stem cell
7	chr17:15181400-15182200	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
8	chr17:15181600-15182200	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
9	chr17:15181600-15182200	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
10	chr17:15181600-15182200	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
11	chr17:15181600-15182200	Flanking Active TSS	H9 Derived Neuron Cultured Cells	ES cell derived
12	chr17:15181600-15182200	Bivalent Enhancer	HUES48 Cell Line	embryonic stem cell
13	chr17:15181600-15182200	Flanking Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
14	chr17:15181600-15182200	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin01	Skin
15	chr17:15181600-15182200	Active TSS	Brain Anterior Caudate	brain
16	chr17:15181600-15182200	Active TSS	Brain Inferior Temporal Lobe	brain
17	chr17:15181600-15182200	Flanking Active TSS	NHLF	lung
18	chr17:15181600-15182400	Enhancers	H1 Cell Line	embryonic stem cell
19	chr17:15181600-15182400	Flanking Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
20	chr17:15181600-15182400	Flanking Active TSS	Muscle Satellite Cultured Cells	--
21	chr17:15181600-15182400	Flanking Active TSS	NHDF-Ad	bronchial
22	chr17:15181600-15182400	Flanking Active TSS	Osteobl	bone
23	chr17:15181600-15182600	Enhancers	ES-WA7 Cell Line	embryonic stem cell
24	chr17:15181600-15183400	Enhancers	Fetal Adrenal Gland	Adrenal Gland
25	chr17:15181600-15183400	Flanking Active TSS	A549	lung
26	chr17:15181800-15182200	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
27	chr17:15181800-15182200	Bivalent/Poised TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
28	chr17:15181800-15182200	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
29	chr17:15181800-15182200	Active TSS	Brain Cingulate Gyrus	brain
30	chr17:15181800-15182200	Active TSS	Brain Hippocampus Middle	brain
31	chr17:15181800-15182200	Active TSS	Brain Dorsolateral Prefrontal Cortex	brain
32	chr17:15181800-15182200	Active TSS	Brain Substantia Nigra	brain
33	chr17:15181800-15182200	Bivalent/Poised TSS	Duodenum Smooth Muscle	Duodenum
34	chr17:15181800-15182200	Enhancers	Fetal Heart	heart
35	chr17:15181800-15182200	Active TSS	Fetal Kidney	kidney
36	chr17:15181800-15182200	Flanking Active TSS	HMEC	breast
37	chr17:15181800-15182200	Flanking Active TSS	NH-A	brain
38	chr17:15181800-15182400	Flanking Active TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
39	chr17:15181800-15182400	Enhancers	Brain Germinal Matrix	brain
40	chr17:15181800-15182400	Enhancers	Fetal Lung	lung
41	chr17:15181800-15182400	Active TSS	Stomach Smooth Muscle	stomach
42	chr17:15181800-15182400	Enhancers	HSMM	muscle
43	chr17:15181800-15182400	Enhancers	NHEK	skin
44	chr17:15181800-15183000	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
45	chr17:15181800-15183200	Enhancers	HSMMtube	muscle
46	chr17:15182000-15182200	Enhancers	HUES6 Cell Line	embryonic stem cell
47	chr17:15182000-15182200	Flanking Active TSS	Ganglion Eminence derived primary cultured neurospheres	brain
48	chr17:15182000-15182400	Flanking Active TSS	ES-I3 Cell Line	embryonic stem cell
49	chr17:15182000-15182400	Enhancers	iPS-15b Cell Line	embryonic stem cell
50	chr17:15182000-15182400	Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links